Tuberculosis (TB) is one of the most significant global health challenges faced by humans. We are proud to be in partnership with QIAGEN to bring the next generation of Latent TB Infection (LTBI) diagnostics to those who need it most.
Tuberculosis (TB) is a respiratory illness that actively infects or is carried by approximately 25% of the global population. More people die of TB than malaria, with 2017 seeing 10 million new cases, including 1 million children. The vast majority of TB cases can be cured through antibiotic treatment and successful eradication programs have proved that diagnosing and reducing LTBI can greatly reduce TB burden of disease.